China has accused GlaxoSmithKline of being at the centre of a “huge” scheme to raise drug prices in three of the country’s biggest cities and said the UK-based drugmaker’s staff had confessed to bribing government officials and doctors.
China’s Ministry of Public Security said a probe in Changsha, Shanghai and Zhengzhou found that GSK had tried to generate sales and raise drug prices by bribing government officials, pharmaceutical industry associations and foundations, hospitals and doctors.
“Following initial questioning, the suspects have confessed,” the ministry said, adding that the investigation was still in progress. It did not state the number of suspects or their positions in the company.
您已閱讀22%（703字），剩余78%（2531字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。